Contact this trialFirst, we need to learn more about you.
FP-045 for Fanconi Anemia
Recruiting1 awardPhase 1 & 2
New York, New York
This trial is testing a new drug, FP 045, to see if it is safe and works well in treating patients with Fanconi anemia who have not had a bone marrow transplant. The trial will enroll 14-18 patients, who will each receive the drug at 3 different dose levels for 28 days each.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.